ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference Press release … Class I) mutations in the CFTR gene using the Company’s Axiomer ® technology platform, and provide an update on other … Oktober 24, 2017
ProQR Announces Positive Top-Line Results from a Phase 1b Study of QR-010 in Subjects with Cystic Fibrosis Press release Key updates September 25, 2017
ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results Press release … develop any new product candidates, including through our Axiomer ® platform, that prior results observed from … Februar 27, 2019